Tuberculosis in Japan: Annual Report 2016 Insights and Trends

Slide Note
Embed
Share

Delve into the Tuberculosis Annual Report 2016 for Japan to explore key statistics, disease notifications, demographics, and trends including foreign-born cases, HIV testing results, drug susceptibility, and more. The report provides a comprehensive analysis of TB cases, age groups affected, geographical distribution, and associated health conditions like diabetes mellitus.


Uploaded on Sep 26, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. TUBERCULOSIS IN JAPAN ANNUAL REPORT 2016

  2. Fig.1 TB case notifications and rates, 2000-2015

  3. Fig 2. Number of TB cases by selected age groups, 2000- 2015

  4. Map 1. TB notification rate by prefectures in Japan, 2015

  5. Fig 3. Proportions of pulmonary and extra-pulmonary diseases by age groups, 2015 PTB bac+: bacteriologically confirmed pulmonary tuberculosis, PTB clin: clinically confirmed pulmonary tuberculosis, ExPTB: extra-pulmonary tuberculosis

  6. Fig 4. Foreign-born TB cases, 2007-2015

  7. Fig 5. Foreign-born TB cases by age groups, 2007- 2015

  8. Fig 6. Foreign-born TB cases by selected countries of birth, 2007-2015

  9. Fig 7. Newly notified cases by HIV test results, 2008- 2015

  10. Fig 8. Newly notified cases by DM status, 2008-2015 DM: diabetes mellitus

  11. Fig 9. Number of culture confirmed PTB cases and of those whose DST results were known, 2007-2015 PTB : pulmonary tuberculosis, DST: drug susceptibility test

  12. Fig 10. Drug susceptibility test results, 2007-2015 MDR: multi-drug resistance, INH res: isoniazid resistant, RFP res: rifampicin resistant

  13. Fig 11. Proportion of those with delay among pulmonary cases, by age groups, 2015 Patient delay: time between onset of symptoms and initial doctor visit being longer than 2 months, Doctor delay: time between initial doctor visit and diagnosis being longer than 1 month Total delay: time between onset of symptoms and TB diagnosis being longer than 3 months

  14. Fig 12. Proportion of those with delay among sputum smear positive pulmonary cases, by age groups, 2015 Patient delay: time between onset of symptoms and initial doctor visit being longer than 2 months, Doctor delay: time between initial doctor visit and diagnosis being longer than 1 month Total delay: time between onset of symptoms and TB diagnosis being longer than 3 months

  15. Fig 13. Proportion of those with delay among extra-pulmonary cases, by age groups, 2015 Patient delay: time between onset of symptoms and initial doctor visit being longer than 2 months, Doctor delay: time between initial doctor visit and diagnosis being longer than 1 month Total delay: time between onset of symptoms and TB diagnosis being longer than 3 months

  16. Fig 14. Treatment outcome of new sputum smear positive cases by age groups (2014 cohort) Age groups

  17. Fig 15. Treatment outcome of new sputum smear positive pulmonary cases aged 49 and below, 2007- 2014

Related


More Related Content